Session F: Innovation, integration, dual testing strategies
Tracks
.
Tuesday, March 14, 2023 |
4:30 PM - 5:30 PM |
Grand Ballroom 2 |
Speaker
Dr Angela Kelly-Hanku
Scientia Associate Professor
PNG Institute of Medical Research and Kirby, UNSW
Accelerating the uptake of innovative approaches for the detection and monitoring of HIV in infants and children (<15 years) in Papua New Guinea
4:30 PM - 4:45 PMBiography
Professor Kelly-Hanku has a background in social science and public health and leads a large multidisciplinary group working on projects in sexual and reproductive health, HIV, violence, gender and sexuality. She holds a joint appointment with the Papua New Guinea Institute of Medical Research and the Kirby Institute UNSW.
Dr Sujith Kumar Prankumar
Senior Research Associate
Kirby Institute for Infection and Immunity in Society, UNSW Sydney
Ms Yumi Sheehan
PhD Candidate / Research Project Manager
The Kirby Institute, University of New South Wales
A ‘one-stop-shop’ intervention integrating point-of-care HCV RNA testing to enhance hepatitis C testing and treatment uptake among new receptions to prison: the PIVOT study
5:00 PM - 5:15 PMBiography
Yumi is a Research Project Manager and PhD candidate at the Kirby Institute UNSW Sydney, managing several hepatitis C and prison-based research studies. Yumi’s specific research focus is on strategies to enhance hepatitis C testing and treatment uptake among people in prison
Mr Rodney Guzman
Research Nurse
Burnet Institute
Evaluating distribution of rapid HCV-antibody self-testing kits to people who inject drugs via needle/syringe vending machines: Outcomes from the VEND-C pilot study
5:15 PM - 5:20 PMBiography
Rodney has had previous clinical nursing experience in fields of Liver Transplant and Neuroscience research. Rodney is currently working as a clinical research nurse at the Burnet Institute in Melbourne on the QuickStart Study. Rodney is presenting on behalf of Daniel O'Keefe.
Mr Shane Tillakeratne
Data Manager, Phd Student
Kirby Institute
Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-infected Patients in Myanmar (Simplified Monitoring Myanmar SM2 study)
5:20 PM - 5:25 PMBiography
Shane is a Data manager at the Kirby Institute within the Viral hepatitis and clinical research program. He is also in his 2nd year of his PhD candidature, examining Hepatitis C virus testing and treatment among recently incarcerated populations utilising data linkage.
Ms. Rugi Bah
PhD Candidate
UNSW
Feasibility and acceptability of blood-borne virus infection point of care testing in prisons: The Australian Hepatitis and risk survey in prisons (AusHep study)
5:25 PM - 5:30 PMBiography
Rugi Bah is a PhD candidate at the Kirby Institute, UNSW. Rugi's doctoral thesis focuses on blood borne virus (BBVs) surveillance in Australian prisons. Her research interests include the health of incarcerated people, the uptake in the care cascade for viral hepatitis B/C in the prisons, and BBVs prevalence.
Chairperson
Pande Putu Januraga
Head
Center For Public Health Innovation
Bev Lawton
Director
Te Tātai Hauora o Hine (National Centre for Women's Health Research Aotearoa), Victoria University Of Wellington